Please provide your email address to receive an email when new articles are posted on . Use of liposomal bupivacaine in an interscalene nerve block effectively controlled pain after outpatient ...
Please provide your email address to receive an email when new articles are posted on . Despite higher pain scores at 8 hours postoperatively and increased opioid use, local infiltration analgesia was ...
TAMPA, Fla., March 29, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today announced ...
Announcing a new article publication for BIO Integration journal. In this article the authors Daowei Lin, Zhixiao Han, Yanni Fu, Xiaoqiu Zhu, Jin Li, Hui Xu, Jing Wen, Fei Wang and Mingyan Guo from ...
TAMPA, Fla., July 10, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NSDQ: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today ...
Prime Hospital Reiterates Commitment Enhancing Healthcare Sector with Ultrasound-Guided Nerve Blocks
DUBAI, United Arab Emirates--(BUSINESS WIRE)--Prime Hospital, one of the UAE's leading healthcare service providers, has achieved another milestone by applying various innovative Anesthetic Techniques ...
In both studies, Exparel achieved a statistically significant reduction in cumulative pain scores from 0 to 96 hours compared with bupivacaine hydrochloride. The Food and Drug Administration (FDA) has ...
Six employees received stock options to purchase an aggregate of 18,000 shares of Pacira common stock and 15 employees ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback